|
Wednesday 2nd December 2020 |
Text too small? |
NZX is today hosting an Investor Day to update analysts and investors on business activities and strategy. The full presentation is available in the Investor Centre on nzx.com.
NZX announced that, based on the performance to date, 2020 EBITDA (operating earnings) is expected to be around the top of the guidance range of $30.0 million to $33.5 million.
This is consistent with the update in NZX’s Interim Results released in August, that there was a greater expectation for the full-year outcome to be towards the top end of the range.
This guidance is subject to market outcomes for the remainder of the year, including total capital raised, secondary market trading and clearing values, derivatives volumes traded, and funds under management and administration growth.
NZX notes the global health and macroeconomic environment remains unusually volatile and guidance assumes no material adverse events, significant one-off expenses, major accounting adjustments or other unforeseen circumstances.
NZX Limited will be announcing results for the year ending 31 December 2020 on 17 February 2021.
See the links below for more details:
NZX Investor Day and Earnings Guidance update
NZX Investor Day 2020 - Presentation
No comments yet
RYM - Ryman Healthcare appoints new independent director
ikeGPS 4Q FY26 and Full Year FY26 Performance Update
HGH - Heartland trading update
CVT - Comvita Rights Offer Opens
GNE - FY26 Q3 Performance Report and Updated Guidance
April 23rd Morning Report
Devon Funds Morning Note - 22 April 2026
AGL - Accordant Group Limited announces opening of Rights Offer
April 22nd Morning Report
BPG - Q4 FY26 Update: ARR reaches $26.8m